Pro odborníky

Randomizované studie 2014

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

Ann Oncol. 2014 Jan;25(1):216-25.

Více informací ZDE

A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study.

Radiother Oncol. 2014 Jan;110(1):98-103.

Více informací ZDE

Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial.

Radiother Oncol. 2014 Jan;110(1):120-5.

Více informací ZDE

An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.

Cancer. 2014 Feb 1;120(3):390-8.

Více informací ZDE

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

N Engl J Med. 2014 Feb 20;370(8):699-708.

Více informací ZDE

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

N Engl J Med. 2014 Feb 20;370(8):709-22.

Více informací ZDE

SPECT Analysis of Cardiac Perfusion Changes After Whole-Breast/Chest Wall Radiation Therapy With or Without Active Breathing Coordinator: Results of a Randomized Phase 3 Trial.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):778-85.

Více informací ZDE

Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):572-9.

Více informací ZDE

Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial.

J Clin Oncol. 2014 Feb 20;32(6):542-7.

Více informací ZDE

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Lancet Oncol. 2014 Feb;15(2):184-90.

Více informací ZDE

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.

Lancet Oncol. 2014 Feb;15(2):164-71.

Více informací ZDE

Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.

Cancer. 2014 Mar 15;120(6):848-54.

Více informací ZDE

The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results.

Strahlenther Onkol. 2014 Mar;190(3):293-7.

Více informací ZDE

The Erlangen Dose Optimization Trial for radiotherapy of benign painful shoulder syndrome. Long-term results.

Strahlenther Onkol. 2014 Apr;190(4):394-8.

Více informací ZDE

Radiotherapy for benign calcaneodynia : Long-term results of the Erlangen Dose Optimization (EDO) trial.

Strahlenther Onkol. 2014 Jul;190(7):671-675.

Více informací ZDE

Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1 cm): a prospective randomized study.

J Am Coll Surg. 2014 Mar;218(3):381-92.

Více informací ZDE

Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial.

J Clin Oncol. 2014 Mar 10;32(8):791-7.

Více informací ZDE

Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.

Radiat Oncol. 2014 Mar 1;9(1):67.

Více informací ZDE

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J Clin Oncol. 2014 Apr 20;32(12):1188-94.

Více informací ZDE

Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.

JAMA. 2014 Apr 2;311(13):1300-7.

Více informací ZDE

Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1074-84.

Více informací ZDE

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.

Lancet Oncol. 2014 Apr;15(4):457-63.

Více informací ZDE

Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB-IVA cervical cancer with or without immunomodulator Z-100: a JGOG study.

Ann Oncol. 2014 May;25(5):1011-.

Více informací ZDE

Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial.

Lancet Oncol. 2014 May;15(6):612-9.

Více informací ZDE

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).

J Clin Oncol. 2014 May 20;32(15):1571-7.

Více informací ZDE

Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):13-20.

Více informací ZDE

Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: Results from the Cambridge Breast IMRT trial.

Radiother Oncol. 2014 May;111(2):270-5.

Více informací ZDE

Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.

Thorac Oncol. 2014 Jun;9(6):825-33J.

Více informací ZDE

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Lancet Oncol. 2014 Jun;15(7):738-46.

Více informací ZDE

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.

Lancet Oncol. 2014 Apr;15(-734):464.

Více informací ZDE

Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa.

Radiother Oncol. 2014 Jul;112(1):23-9.

Více informací ZDE

Effects of voice rehabilitation after radiation therapy for laryngeal cancer: a randomized controlled study.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):964-72.

Více informací ZDE

Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)..

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):958-63 .

Více informací ZDE

Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):110-8.

Více informací ZDE

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer.

J Clin Oncol. 2014 Sep 1;32(25):2735-43.

Více informací ZDE

Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.

J Clin Oncol. 2014 Aug 10;32(23):2416-22.

Více informací ZDE

Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.

J Clin Oncol. 2014 Aug 10;32(23):2456-62.

Více informací ZDE

Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy--25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group.

Eur J Cancer. 2014 Sep;50(13):2201-10.

Více informací ZDE

Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trial.

Br J Radiol. 2014 Sep;87(1041):20140212.

Více informací ZDE

Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.

Eur J Cancer. 2014 Sep;50(14):2390-8.

Více informací ZDE

Consequences of anorectal cancer atlas implementation in the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target delineation study.

Radiother Oncol. 2014 Sep;112(3):418-24.

Více informací ZDE

Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):255-60.

Více informací ZDE

Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):289-95.

Více informací ZDE

No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT).

Radiother Oncol. 2014 Nov;113(2):223-9.

Více informací ZDE

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

J Clin Oncol. 2014 Nov 10;32(32):3613-8.

Více informací ZDE

Effects of a dietary intervention on gastrointestinal symptoms after prostate cancer radiotherapy: Long-term results from a randomized controlled trial.

Radiother Oncol. 2014 Nov;113(2):240-7.

Více informací ZDE

Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):526-31.

Více informací ZDE

Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):756-64.

Více informací ZDE

Evaluating the effects of aluminum-containing and non-aluminum containing deodorants on axillary skin toxicity during radiation therapy for breast cancer: a 3-armed randomized controlled trial.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):765-71..

Více informací ZDE

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

Lancet Oncol. 2014 Sep;15(10):1076-89.

Více informací ZDE

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

J Clin Oncol. 2014 Sep 20;32(27):2940-50.

Více informací ZDE

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Lancet Oncol. 2014 Nov;15(12):1303-10.

Více informací ZDE

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.

Lancet Oncol. 2014 Nov;15(12):1397-406.

Více informací ZDE

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

J Clin Oncol. 2014 Dec 1;32(34):3858-66.

Více informací ZDE

6